Quantum Biopharma Ltd. Files April 2025 6-K Report
Ticker: QNTM · Form: 6-K · Filed: Apr 14, 2025 · CIK: 1771885
| Field | Detail |
|---|---|
| Company | Quantum Biopharma Ltd. (QNTM) |
| Form Type | 6-K |
| Filed Date | Apr 14, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, sec-filing, foreign-private-issuer
TL;DR
Quantum Biopharma (fka FSD Pharma) filed their April 6-K, sticking with 20-F.
AI Summary
Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on April 14, 2025, reporting for the month of April 2025. The company, incorporated in A6 and headquartered in Toronto, Canada, operates in the Pharmaceutical Preparations sector (SIC 2834). This filing indicates they are submitting their report under Form 20-F.
Why It Matters
This filing provides an update on Quantum Biopharma's regulatory reporting status, confirming their submission of a Form 6-K for April 2025 and their adherence to Form 20-F reporting requirements.
Risk Assessment
Risk Level: low — This is a routine reporting filing and does not contain new financial or operational information that would inherently increase risk.
Key Players & Entities
- Quantum Biopharma Ltd. (company) — Filer
- FSD Pharma Inc. (company) — Former company name
- April 14, 2025 (date) — Filing date
- 20250414 (date) — Conformed period of report
- 001-39152 (other) — SEC file number
- 2834 (other) — Standard Industrial Classification (Pharmaceutical Preparations)
- Form 20-F (other) — Annual report form
- Form 6-K (other) — Report type
FAQ
What is the primary purpose of this Form 6-K filing?
The Form 6-K is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of April 2025.
What was Quantum Biopharma Ltd.'s former name?
Quantum Biopharma Ltd.'s former company name was FSD Pharma Inc., with a date of name change on March 27, 2019.
What is Quantum Biopharma Ltd.'s Standard Industrial Classification (SIC) code and industry?
The company's SIC code is 2834, which corresponds to Pharmaceutical Preparations.
Which annual report form does Quantum Biopharma Ltd. indicate it files?
The registrant indicates it files annual reports under cover of Form 20-F.
Where is Quantum Biopharma Ltd.'s principal executive office located?
The principal executive office is located at 55 University Ave., Suite 1003, Toronto, Ontario M5J2H7, Canada.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 14, 2025 regarding Quantum Biopharma Ltd. (QNTM).